ELISA Analyzer Market Growth and Revenue Analysis By Top Players - Siemens Healthineers, Awareness Technology, Dynes Technologies, EUROIMMUN AG, Robimes, Gold Standard Diagnostics

Enzyme Linked Immunosorbent Assay (ELISA) is a biochemical assay, which use antibodies and an enzyme-mediated color change to detect the presence of either antigen (proteins, peptides, and hormones) or antibody in sample. Enzyme-linked immunosorbent assay is used as diagnostic tool in medicine and analytical tool in biomedical research. ELISA analyzer is an instrument used for detecting the concentration and presence of analyte in the test sample.

Download The PDF Brochure : https://www.coherentmarketinsights.com/insight/request-pdf/1850

ELISA analyzer can be used are a part of workflow were reagents and consumables are fed to carry out ELISA and results are displayed on the screen attached to it, which is known as automated ELISA analyzer. Increasing array of products to ease the workflow is the major factor driving the ELISA analyzer market growth over the forecast period. Moreover, increasing prevalence of infectious disease and drug development are also expected to fuel the ELISA analyzer market growth over the forecast period. However, stringent regulatory policies for product approval are expected to hinder the new product launches, which in turn is restraining growth of the market.

ELISA Analyzer Market Dynamics
New product launches with increased sophistication and value added testing environment to enhance sensitivity coupled with compactness of product are expected to fuel growth of the ELISA analyzer market over the forecast period. For instance, in 2017, Siemens Healthineers, received CE approval for Atellica Solution, an automated immunoassay and chemistry analyzers in Europe, the U.S., South America, and Asia. The product has comprehensive menu of 170 assays, which include cardiac, thyroid, and reproductive tests. Furthermore, the company has pipeline of about 50 more assays, which are expected to be added to the present menu.

ELISA Analyzer Market – Regional Analysis
Regional segmentation of the market by Coherent Market Insights includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America ELISA analyzer market holds dominant position in global market, owing to increasing burden of infectious disease, adoption of immunoassays in diagnosis, and presence of local market players. For instance, according to National Ambulatory Medical Care Survey, 2015, in the U.S. around 16.8 million visits were reported to physician offices for infectious and parasitic diseases.

ELISA Analyzer Market – Competitive Analysis
Key players operating in the ELISA analyzer market include Siemens Healthineers, Awareness Technology, Inc., Dynes Technologies, Inc., EUROIMMUN AG, Robimes, Gold Standard Diagnostics, Corp., BioTek Instruments, Inc., and Berthold Technologies GmbH & Co. KG.

Market players are adopting growth strategies such as merger, acquisition or geographical expansion. For instance, in 2016, Gold Standard Diagnostics, Corp. and R-BioPharma AG collaborated on multiple technology and marketing initiatives to leverages respective strength of both companies to expand product offering and geographic sales coverage. In 2013, Gold Standard Diagnostics, Corp. established distribution partnership for the ThunderBolt automated immunoassay analyzer in 18 countries since its launch in 2012.

Ask For Sample Copy of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/1850

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.